Physician profile

Pardeep Kumar Thourani

Internal Medicine · Urbana, IL

NPI 1013324748

$124.18

in general payments reported to CMS, 2019-2025

2 companies · $50.55 in 2025

The $50.55 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$50.55

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $73.63 2019
Novo Nordisk INC $50.55 2025 Rybelsus, Ozempic

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Pardeep Kumar Thourani

$124.18

in general payments reported 2019-2025

Years
2019-2025
Top company
Stryker Corporation
Context
The $50.55 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).

https://glasscript.com/doctor/562732/pardeep-kumar-thourani

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.